On Simon's two‐stage design for single‐arm phase IIA cancer clinical trials under Beta‐binomial distribution

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Statistics in Medicine

• Publication date

  2010-05-10

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1002/sim.3805PMID 20077506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bayesian data analysis.

  2010cited by this paper
• Hypothesis Test

  2009cited by this paper
• Elicitation of a Beta Prior for Bayesian Inference in Clinical Trials

  2008cited by this paper
• Proper inference from Simon's two‐stage designs

  2008cited by this paper
• Curtailed two‐stage designs in Phase II clinical trials

  2008cited by this paper
• Optimal and minimax three-stage designs for phase II oncology clinical trials.

  2008cited by this paper
• A Bayesian predictive two‐stage design for phase II clinical trials

  2008cited by this paper
• A predictive probability design for phase II cancer clinical trials

  2008cited by this paper
• Approaches to handling data when a phase II trial deviates from the pre‐specified Simon's two‐stage design

  2008influential reference
• Balanced two-stage designs for phase II clinical trials

  2007cited by this paper
• Bayesian two‐stage designs for phase II clinical trials by S. B. Tan and D. Machin, Statistics in Medicine 2002; 21:1991–2012

  2006cited by this paper
• Adaptive two‐stage designs in phase II clinical trials

  2006cited by this paper
• Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors

  2006cited by this paper
• Bayesian Data Analysis, 2nd edn

  2005cited by this paper
• Bayesian designs with frequentist and Bayesian error rate considerations

  2005cited by this paper
• Adaptive Two‐Stage Designs for Single‐Arm Phase IIA Cancer Clinical Trials

  2004influential reference
• Bayesian sample size calculations in phase II clinical trials using informative conjugate priors.

  2004cited by this paper
• An optimal two-stage phase II design utilizing complete and partial response information separately.

  2002cited by this paper
• Bayesian two‐stage designs for phase II clinical trials

  2002cited by this paper
• Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer.

  2002cited by this paper
• Uniform power method for sample size calculation in historical control studies with binary response.

  2001cited by this paper
• Graphical search for two-stage designs for phase II clinical trials.

  2001cited by this paper
• Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials.

  1998cited by this paper
• Bayesian interim analysis of phase II cancer clinical trials.

  1997cited by this paper
• Optimal three-stage designs for phase II cancer clinical trials.

  1997cited by this paper
• A Bayesian approach to establishing sample size and monitoring criteria for phase II clinical trials.

  1994cited by this paper
• Practical Bayesian guidelines for phase IIB clinical trials.

  1994cited by this paper
• A Bayesian approach to establishang sample size and monitoring criteria for phase II clinical trials

  1994cited by this paper
• Optimal two-stage designs for phase II clinical trials.

  1989influential reference
• A bayesian approach to the design of phase II clinical trials.

  1988cited by this paper
• Food and Drug Administration's requirements for markers.

  1984cited by this paper

• Statistical methodologies for absolute and relative efficacy assessment based on single-arm trials: a scoping review.

  2026cites this paper
• The use of local and nonlocal priors in Bayesian test‐based monitoring for single‐arm phase II clinical trials

  2021cites this paper
• Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial

  2019cites this paper
• Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints

  2018cites this paper
• Bayesian Two-Stage Design for Phase II Clinical Trials with Switching Hypothesis Tests

  2017cites this paper
• On a Type of Probability Stopping Rule for Toxicity Study

  2013cites this paper
• A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome.

  2013cites this paper
• On the Time to Conclusion of Phase II Cancer Clinical Trials and Its Application in Trial Designs

  2012influential citation
• A type of sample size design in cancer clinical trials for response rate estimation.

  2011cites this paper